Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Clinical trial NCT04631744 · TERMINATED

Trial details

NCT number: NCT04631744
Sponsor: Weill Medical College of Cornell University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2021-03-03
Primary completion: 2025-05-12
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.